Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Taysha Gene Therapies Inc
(NQ:
TSHA
)
2.310
+0.030 (+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Taysha Gene Therapies Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 26, 2022
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 26, 2022
It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 25, 2022
Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.
Via
Benzinga
Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings
October 25, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
Expert Ratings for Taysha Gene Therapies
May 17, 2022
Within the last quarter, Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings:
Via
Benzinga
Taysha Gene Therapies: Q1 Earnings Insights
May 16, 2022
Taysha Gene Therapies (NASDAQ:TSHA) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
October 26, 2022
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 25, 2022
Gainers
Via
Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Via
Benzinga
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session
October 25, 2022
Gainers
Via
Benzinga
S&P 500 Rises Over 1%; General Motors Earnings Top Views
October 25, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday.
Via
Benzinga
Analyzing Taysha Gene Therapies's Short Interest
October 25, 2022
Taysha Gene Therapies's (NASDAQ:TSHA) short percent of float has fallen 5.27% since its last report. The company recently reported that it has 889 thousand shares sold short, which is 4.31% of all...
Via
Benzinga
Why Is Xerox (XRX) Stock Down 20% Today?
October 25, 2022
Xerox (XRX) stock is heading lower on Tuesday thanks to the release of its earnings report for the third quarter of 2022.
Via
InvestorPlace
Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics
October 25, 2022
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic
Via
Spotlight Growth
What Is Going on With Taysha Gene (TSHA) Stock Today?
October 25, 2022
Taysha and its new partner Astellas are both speculating that Adeno Associated Viruses can create treatments for genetic diseases.
Via
InvestorPlace
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
October 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 25, 2022
Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 25, 2022
We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!
Via
InvestorPlace
Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket
October 25, 2022
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Taysha Gene Therapies
August 12, 2022
Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 25, 2022
On Wednesday, 215 companies set new 52-week lows.
Via
Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
August 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 24, 2022
On Tuesday, 540 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
May 16, 2022
On Monday, 198 companies reached new 52-week lows.
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
What 6 Analyst Ratings Have To Say About Taysha Gene Therapies
April 01, 2022
Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter:
Via
Benzinga
10 Biggest Price Target Changes For Friday
April 01, 2022
Wells Fargo lowered the price target on General Motors Company (NYSE: GM) from $83 to $72. GM shares rose 0.8% to $44.10 in pre-market trading.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 29, 2022
On Friday, 213 companies hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.